Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T‐cell responses to SARS‐CoV‐2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine
Yongzheng Li, Xiuwen Wang, Junyan Jin, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3998-4004
Open Access | Times Cited: 24

Showing 24 citing articles:

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 113
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
Patricia Almendro-Vázquez, Marta Chivite-Lacaba, Alberto Utrero‐Rico, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
Xiuwen Wang, Xiaodong Yang, Xin Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
Gang Yang, Junxiang Wang, Ping Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The Immunogenicity of CpG, MF59-Like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice
Kangwei Xu, Jing Li, Lu Xu, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 60-60
Open Access | Times Cited: 2
SARS-CoV-2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination
Xiuwen Wang, Yongzheng Li, Junyan Jin, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 2
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108673-108673
Open Access | Times Cited: 7
Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
Jianzhong Zhang, Yutian Xia, Xuan Liu, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 148-148
Open Access | Times Cited: 6
Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine
Ruoqiong Huang, Liyang Ying, Jiangmei Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context
Ioannis Alexandros Charitos, Andrea Ballini, Roberto Lovero, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10712-10712
Open Access | Times Cited: 10
Immunodominant SARS‐CoV‐2‐specific CD4 + and CD8 + T‐cell responses elicited by inactivated vaccines in healthy adults
Jie Ning, Qinjin Wang, Ying Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 5
Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV
Akshita Gupta, Elda Righi, Angelina Konnova, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 1
Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine
Junyan Jin, Xiuwen Wang, Yongzheng Li, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 24, pp. 2938-2947
Open Access | Times Cited: 4
Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
Shuyi Wang, Jin Li, Shuang Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Next generation sequencing shows diversity of Omicron sub-lineages of SARS-COV2 circulating in Jeddah, Saudi Arabia
Ahmed Bouna, Ahmed Atef, Hadiah Bassam Al Mahdi, et al.
Journal of King Saud University - Science (2023) Vol. 36, Iss. 2, pp. 103081-103081
Open Access
The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated COVID-19 vaccine in healthy adults
Supaporn Suparak, Kobkaew Bumroongthai, Danai Jantapalaboon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top